Zobrazeno 1 - 10
of 4 177
pro vyhledávání: '"Chronic Inflammatory Demyelinating polyneuropathy"'
Autor:
Milou R. Michael, Luuk Wieske, Jeffrey A. Allen, Michael P. Lunn, Kathrin Doppler, Cheng-Yin Tan, Haruki Koike, Lars K. Markvardsen, Mahima Kapoor, Sung-Tsang Hsieh, Eduardo Nobile-Orazio, Bart C. Jacobs, Yusuf A. Rajabally, Ivana Basta, Paolo Ripellino, Luis Querol, Filip Eftimov, on behalf of the INCbase Consortium
Publikováno v:
BMC Neurology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background INCbase is an international, multicenter prospective observational study using a customizable web-based modular registry to study the clinical, biological and electrophysiological variation and boundaries of chronic inflammatory d
Externí odkaz:
https://doaj.org/article/b9782e9aad8c4a3b931a9b41ad79134b
Publikováno v:
National Journal of Laboratory Medicine, Vol 13, Iss 03, Pp 16-21 (2024)
Introduction: Peripheral neuropathy is common in clinical practice, with a reported prevalence of 2.4% in the general population. There are numerous aetiologies for peripheral neuropathy like diabetes, ischaemia, vasculitis, inflammatory demyelinatin
Externí odkaz:
https://doaj.org/article/0024328b4df742bd8ac5995c998db16a
Autor:
Wiktoria Rałowska-Gmoch, Magdalena Koszewicz, Beata Łabuz-Roszak, Sławomir Budrewicz, Edyta Dziadkowiak
Publikováno v:
Experimental and Molecular Pathology, Vol 140, Iss , Pp 104942- (2024)
Guillain-Barré syndrome (GBS) and acute-onset chronic inflammatory demyelinating polyneuropathy (A-CIDP) are the most common autoimmune polyneuropathies. Their aetiology is unclear. The pathomechanism includes damage mainly to the myelin sheath and,
Externí odkaz:
https://doaj.org/article/e4de34671bf748c5b913ae74d04f98c6
Publikováno v:
Клинический разбор в общей медицине, Vol 5, Iss 5, Pp 28-32 (2024)
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an orphan disease of the peripheral nervous system. The clinical phenotypes of CIDP may influence the choice of primary pathogenetic therapy. In some cases, viral infection may be a trigger
Externí odkaz:
https://doaj.org/article/e2c6cbe24a6e409fb1dd740585a822fd
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 18, Iss 1, Pp 98-104 (2024)
Neurological immune-related adverse events (irAE) are rare but potentially fatal complications associated with the use of immune checkpoint inhibitors (ICI). Recently, there has been a trend towards an increase in the incidence of these cases. We
Externí odkaz:
https://doaj.org/article/060c4a10e4034eea89edf22fd59b780e
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
BackgroundChronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disease, and the potential risk of cancer in patients with CIDP remains an important concern during treatment. However, a comprehensive epidemiological study examining this
Externí odkaz:
https://doaj.org/article/a8aa3f7b5bf040629c364fe41f165c2d
Autor:
Garcia‐Castillo María Ariana
Publikováno v:
Clinical Case Reports, Vol 12, Iss 8, Pp n/a-n/a (2024)
Key Clinical Message Patients affected by chronic inflammatory demyelinating polyradiculoneuropathy require close follow up due to the neuronal demyelination along with axonal degeneration associated with the disease process, giving the opportunity t
Externí odkaz:
https://doaj.org/article/8ea127778e6f47379de621b28b917018
Publikováno v:
Frontiers in Nuclear Medicine, Vol 4 (2024)
Peripheral neuropathy is a prevalent complication in plasma cell disorders, posing significant diagnostic and therapeutic challenges. This study presents three cases initially diagnosed with chronic inflammatory demyelinating polyneuropathy (CIDP). D
Externí odkaz:
https://doaj.org/article/975663e0f7d04bf1adc42d7b6d5c0977
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/7b0bed51b0f842bb8840d2bb76df4d4d
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectivesChronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated neuropathy defined by clinical progression for more than 2 months. 16-20% of CIDP patients may present with rapidly progressive weakness that resembles
Externí odkaz:
https://doaj.org/article/2c9c8d0019e24198b8cc88519802f7d8